Apple Tree Partners funds a $52M Series A for Deep Apple to leverage virtual screening

blonca9
Dec 14, 2023
1 min read

Apple Tree Partner and Deep Apple CEO Spiros Liras describes how the company aims to leverage virtual screening and machine learning to accelerate drug discovery.

Recent Posts

See All

Talking chromatin regulation at Foghorn Therapeutics - whose partner Lilly will have preclinical data at AACR highlighting how the lead SMARCA2 program could do in combinations with other therapies

AI news: Epicrispr Biotechnologies' CEO Amber Salzman describes how her company will be utilizing AI muscle analysis in its clinical study for facioscapulohumeral muscular dystrophy

Lexeo Therapeutics' CEO Nolan Townsend highlights recent FA cardiomyopathy data and the path ahead in that indication. Plus, the latest on PKP2 ACM, and more

Apple Tree Partners funds a $52M Series A for Deep Apple to leverage virtual screening

Recent Posts

Join the BiotechTV mailing list

Follow BiotechTV

Sponsors

Sponsor Spotlight